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Introduction
Patellofemoral (PF) osteoarthritis (OA) can be associated with
anterior knee pain, stiffness, and functional impairment.1
Some authors report that approximately 9% of patients older
than 40 years are affected by PFOA.2 Other authors have
reported an incidence ranging from 2 to 11% in men and
from 8 to 24% in women older than 55 years.3,4 The higher
incidence in female patients may be related to a higher
incidenceofPFmalalignmentanddysplasia in thispopulation.5
Furthermore, Kobayashi et al6 in a recent systematic review,
including 32 studies, concluded that the prevalence of PFOA
was 25% in the asymptomatic population (age > 20 years) and
39% in the symptomatic population (age > 30 years).
The development of PFOA is related to the presence of
abnormal PF joint stress, which can be due to excessive
amount or inadequate dispersion of forces. The cause of
these abnormal stresses is multifactorial, including both
knee- and patient-related risk factors.7
Among the patient-related risk factors, increased body
mass index (BMI) surely increased the forces on the PF joint
during weight-bearing activities.8,9 Some authors outlined
female gender and increased age to be possible risk factors
for PFOA, as well as activities involving increased load on PF
joint (i.e., descending stairs).7 Previous trauma to the PF joint
(i.e., patellar fracture or dislocation) has also been related to
the development of PFOA.10,11
Amongknee-related risk factors, increased rate of PFOAhas
been reported in patients who underwent anterior cruciate
ligament reconstruction (ACLR), with a median prevalence of
up to 50% at 10 to 15 years after surgery.12Quadriceps and hip
abductor weakness has also been related to PFOA, as well as
ileotibial bandandhamstring contracture.7However, themost
important knee-related risk factor is the presence of PF
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Abstract Patellofemoral osteoarthritis (PFOA) can be associated with anterior knee pain,
stiffness, and functional impairment. Some authors report that PFOA affects approxi-
mately 9% of patients older than 40 years with a greater prevalence in females. Etiology
of PFOA is multifactorial and is related to the presence of abnormal stresses at the PF
joint due to knee- and patient-related factors. The need for a joint preserving treatment
by isolated replacement of the injured compartment of the knee led to the develop-
ment of PF arthroplasty (PFA). When a correct PF replacement is performed, PFA
preserves physiologic tibiofemoral joint, thus allowing patients for a rapid recovery
with a high satisfaction. The outcomes for PFA are quite variable with a trend toward
good to excellent results, mainly owing to the improvement in surgical techniques,
patient selection, and implant design. The development of the second generation of
PFA improved the outcomes, which is attributed to the different trochlear designs.
Recently, encouraging results have been provided by the association of PFA and
unicompartmental knee arthroplasty (UKA). In many studies, the main cause of PFA
failure is progression of tibiofemoral OA. The aim of this brief review of literature is to
summarize the clinical features, indications and contraindications, surgical techniques,
complications, and outcomes of PFA.
published online
October 4, 2017
DOI https://doi.org/
10.1055/s-0037-1606618.
ISSN 2282-4324.
Copyright © 2017 Georg Thieme
Verlag KG Stuttgart · New York
THIEME
Review Article 237
malalignment or trochlear dysplasia, as well as valgus knee
alignment and increased femoral anteversion.7,13,14
Treatment of PFOA includes nonoperative and surgical
options. The nonoperative treatments include exercise, physi-
cal therapy, taping, and injectionsandmay result in short-term
benefit.14Thesurgical options range fromjointdebridement to
arthroplasty. However, joint-preserving procedures, including
anterior tibial tubercle transfer or cartilage procedures, may
lead to insufficient short-term improvement. Total knee ar-
throplasty (TKA) with patellar replacement is a well-estab-
lished procedure to treat PFOA, but anterior knee pain may
persist in 7 to 19% of the patients.4,10
The need for replacing the PF joint while maintaining a
joint kinematic closer to that of the native knee in compar-
ison with TKA led to the development of PF arthroplasty
(PFA).4 PFA preserves physiologic tibiofemoral joint, thus
allowing patients for a rapid recovery with good satisfac-
tion.15 Although PFA is considered a valid therapeutic option
to treat isolated PFOA, it is indicated in a small and highly
selected population.
The first PFAwas proposed in 1955 byMacKeever. Despite
the initial encouraging results, it was quickly abandoned due
to excessive wear in the trochlear groove.16 PFA witnessed a
rebirth in the 1970s, when the first generation of Richards’
prostheses (Smith & Nephew; Memphis, Tennessee, United
States) was introduced and subsequently developed later in
the 1990s with the introduction of the second generation of
PFA.17,18 Although the clinical outcomes after PFA depend
primarily on implant design and surgical technique, careful
patient selection with very strict inclusion and exclusion
criteria is mandatory for long-term survivorship and satis-
factory outcomes.
The aim of the this article is to summarize the clinical
features, indications and contraindications, surgical techni-
ques, and outcomes of PFA.
Patellofemoral Osteoarthritis
Patient History and Physical Examination
Patients with isolated PFOA report an anterior or retropatellar
knee pain, usually associated with activities that load the PF
joint.4 These activities include squatting, ascending or des-
cending stairs, rising from a seated position, or prolonged
sitting with flexed knees.4 Frequently, some activities, such as
full squatting and kneeling, are almost impossible. Pain is less
severewhenwalking on level ground and in standing position
with the knee completely extended.11 Frequently, patients
affected by PFOA experience theworse pain in the early stages
of the disease.11
Duringphysical examination, it ismandatory toevaluate the
entire lower limb, including muscle strength and coronal and
PF malalignment (i.e., an increased Q angle). Indeed, the pre-
senceofmalalignmentshouldbecarefullyevaluatedbecause in
many cases a realignment osteotomy before or in conjunction
with PFA may be required.4 Crepitus and effusion may be
reported, and the patella compression test is often positive in
the case of PFOA. The range of motion (ROM) must be inves-
tigated, and the examiner should focus on the localization of
painand its correlation to thedegreeofflexion.Normally, distal
lesions (inferior pole) are painful at the first degree of flexion,
while proximal lesions are painful at higher flexion.19 It is also
mandatory to evaluate patella tracking throughout the entire
kneeROMto assessmaltrackingor instability (i.e., thepresence
of a J sign).20,21 Any involvement of the tibiofemoral joint
should be ruled out, as well as knee stability, to avoid pro-
gressive tibiofemoral OA and/or instability. Furthermore, the
neurovascular status, previous scars, and hip and lumbar spine
status should be carefully evaluated.4
Imaging
A routine series of conventional X-ray views should be
obtained, including standing anteroposterior (AP), flexed
weight-bearing posterior–anterior (PA, Rosenberg), lateral,
and sunrise (Merchant) views. Both the PF and tibiofemoral
joints should be carefully evaluated on these films. Sunrise
views at 30 degreesflexion allow for the best assessment, but
in some cases, it is useful to take views in various degrees of
flexion to better evaluate patellar tilt, subluxation, trochlear
dysplasia, or a narrowed joint space.22 Lateral viewcan reveal
PF osteophytes, patella height, and joint space narrowing. AP
and PA views can reveal a medial or lateral OA. A weight-
bearing, long-leg view should also be obtained to evaluate
lower limb alignment. Some authors suggest additional
computed tomography (CT) scan and/or magnetic resonance
imaging (MRI) to calculate the tibial tubercle–trochlear
grove (TT–TG) distance and evaluate bone stock, rotational
malalignment, trochlear dysplasia, and intra-articular struc-
tures (articular cartilage, menisci, and ligaments).3,4,21
Patellofemoral Arthroplasty: Indications
and Contraindications
A prerequisite for the success of PFA is a proper patient
selection to avoid complications.5,17,23–25 Themost common
indication for PFA is severe primary isolated PFOA that affects
daily activities without relief from conservative treatment.
PFA is also indicated in patients with posttraumatic PFOA,
isolated trochlear dysplasia, patellar subluxation, or failure
of previous extensor mechanism unloading procedures, such
as Fulkerson or Maquet osteotomy.5,11,25–27 Moreover, the
ideal patient age ranges from 40 to 60 years.28,29
Many contraindications exist to PFA that should always be
kept in mind. The presence of tibiofemoral OA is the most
common contraindication and the most common cause of
PFA failure.5 PF malalignment, with an increased Q angle,
cannot be corrected by PFA alone; so, it has to be considered
as a relative contraindication. On the contrary, mild patellar
tilt or subluxation can be corrected at the time of PFA with
lateral retinacular release, medialization of the patellar
component, or partial facetectomy.4 A PFA should preserve
normal knee kinematics, joint stabilitywith intact ligaments,
and menisci has to be considered as a fundamental prere-
quisite for PFA.4 Furthermore, PFA is contraindicated in the
presence of severe uncorrected coronal plane deformity
(valgus > 8 or varus > 5 degree alignment) or sagittal plane
deformity (120 degree flexion with < 10 degree flexion
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contracture).4,11,28 Active infection and evidence or high
suspicion of chronic regional pain syndrome are also contra-
indications to PFA.11,23 Quadriceps atrophy, patellar tendon
scarring, patella baja, and excessive BMI (>30) represent
relative contraindications to PFA, as have been correlated to
poorer outcome.11,23 Hence, the ideal candidate for PFA is a
middle age patient affected by isolated, debilitating nonin-
flammatory PFOA not responsive to conservative treatment
and with normal limb alignment.4 The main indications and
contraindications are summarized in ►Table 1.
Implant Design
The first PFA designwas an isolated resurfacing of the patella
with a screw-on Vitallium patellar shell. Despite initial
encouraging results, it was quickly abandoned due to ex-
cessive wear in the trochlear groove.16,30
The first generation of complete PFA (both sides) only
replaced the trochlear cartilage leaving the subchondral
bone intact (inlay design); so, the position of the PFA was
related to the anatomyof the native trochlea. Furthermore, the
trochlear component was positioned flushwith the surround-
ing cartilage, the rotational alignment was parallel to the
trochlear inclination, the mediolateral coverage was limited,
and the surgical technique was mainly free hand.31 First-
generation PFA was successful in the short-term period, pro-
viding early pain relief, but the results were not maintained
over time andmore than 50% of the implants failed in themid-
to long-term follow-up with high reoperation rate.32
The second-generation PFA was designed to improve
clinical outcomes and address the limitations of the previous
design,mainly related tomaltracking and instability.31 These
implants used the same anterior femoral cuts as in TKA and
completely replaced the anterior compartment of the knee
(onlay design). Furthermore, these were characterized by a
broad trochlear flange that narrowed distally,18 a valgus
tracking angle and a good congruity throughout the entire
ROM, avoiding catching, snapping, or popping.4
Both generations include symmetric and asymmetric
implants. The second-generation designs can be used in all
patients, regardless of anatomic variations, and are therefore
more versatile and suitable.21
The PF implants can also be sorted according to the
morphology of each component. The patellar button can be
shaped with facets or as a dome and can be symmetric or
asymmetric. It is advisable that patellar button design match
the trochlear shape of TKAs to allow for retention of the
component, if a PFA revision is required.33
Nevertheless, the evolution of PFA is mostly based on the
design of the trochlear component. The sagittal radius of
curvature, themediolateral width, the distal–proximal exten-
sion, and the grade of constrain are the most important
features of the trochlear design.34 A less constrained design
allows the patella for more freedom but may increase the risk
of patellar instability. On the contrary, a more constrained
design (deep trochlear groove) allows less patellar movement
causing an increase in PF loads and a high risk of early
loosening.33 Consequently, the goal of implant design is to
reproduce as close as possible the normal anatomy, thereby
allowing smooth patellar tracking and minimizing the risk of
subluxation or dislocation.34–36 The sagittal radius of curva-
ture and the proximal extension of the implant determine the
point of engagement of the patellar button with the trochlear
component.37 These parameters can significantly influence
patellar tracking. Furthermore, the point at which the patellar
button engages the trochlear component is also influenced by
the distal coverage of the implant.33
Nowadays, inlay implants have been mostly abandoned
and onlay implants are mainly used worldwide.
Surgical Technique (Onlay Design)
After a midline incision (from 1 cm proximal to the patella to
just proximal to the tibial tubercle), the arthrotomy can be
performed using surgeon’s choice between medial parapa-
tellar, midvastus, or subvastus approach. Care must be taken
to avoid damaging the menisci, ligaments, or tibiofemoral
articular cartilage. The patella can be either laterally dis-
located or left in place and gently and partially everted. At
this point, the surgeon should inspect the entire knee to
confirm that the tibiofemoral joint is not involved and there
are no ligamentous injuries.
The precise technique of implantation varies with the
implant used. As a general rule, the trochlea is preparedwith
an anterior cutting guide, taking care not to damage the
anterior cortex of the femur.33
Evaluation of the correct rotational alignment is manda-
tory to obtain good outcomes, and it can be achieved using
an intramedullary femoral guide, navigation, or robotic
devices.38,39
The anterior femoral cut can be either performed in an
“anatomical”or “functional” fashion. The “anatomical”anterior
Table 1 Indications and contraindications for PFA
Indications Contraindications
Advanced primary
isolated PFOA
Absolute contraindications
Posttraumatic PFOA Tibiofemoral OA
Trochlear dysplasia PF malalignment
Patellar subluxation
or mild patellar tilt
Knee instability
(ligaments and/or menisci injuries)
Failed extensor
mechanism
unloading
procedures
Limb malalignment
(Valgus deformity > 8 degrees
or varus deformity > 5 degrees)
Age > 40 years Acute infection or CRPS
Relative contraindications
Quadriceps atrophy
Patella baja
BMI > 30
Abbreviations: BMI, body mass index; CRPS, complex regional pain
syndrome; OA, osteoarthritis; PF, patellofemoral; PFA, patellofemoral
arthroplasty; PFOA, patellofemoral osteoarthritis.
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femoral cut is performed perpendicular to the AP axis (White-
side’s line) or parallel to the transepicondylar axis and then the
patella is recentered by freeing up the lateral retinaculum.
Alternatively, the “functional” femoral cut can be performed
with more external rotation relative to the patellar plane and
can be combined with lateral translation of the femoral
component to avoid additional procedures on the extensor
mechanism.33
Once the appropriate rotation is obtained, the anterior cut
is performed and the appropriate size of the trochlear
component is selected. The presence of the “grand piano”
is the sign of a good external rotation of the component. The
sign is an image, resembling a grand piano, that results on the
anterior cut of the femur as a consequence of the asymmetric
anterior cut.11 To avoid maltracking, the cutting guide and
then the definitive implant, should be placed slightly lateral.
Once the femur has been prepared, the trial component is
impacted to make sure there is no ACL impingement and no
stepoff with the condylar cartilage.
The patellar cut is performed as in the standard TKA. It is
important to leave at least 14 mm of bone thickness, and care
must be taken to avoid asymmetric cut and overstuffed
component. If it is not possible to leave an adequate amount
of bone stock, a bone graft, and cement or patella augmenta-
tion button are viable solutions.40 To prevent maltracking, the
patellar component should be medialized and the lateral
osteophytes shouldbe removed to avoid bony impingement.11
The patella tracking should be carefully checked with trial
components. If it is not adequate, a lateral release can be
performed. In case of more severe malalignment, advance-
ment of the vastus medialis or tibial tubercle transfer can be
performed. However, these procedures should be carefully
planned preoperatively, and worse outcomes can be ex-
pected.33,40When the correct size and position of the implant
are achieved, the trial components are removed and the
definitive components are cemented. Surgeons should be
careful to avoid thermal damage to the adjacent cartilage
during cementation (►Fig. 1).
Postoperative Rehabilitation
Postoperative care follows the same indications as in the
TKA. Full weight bearing is immediately allowed as tolerated.
Rehabilitation focuses on active and passive ROM exercises
along with gait training. In case of additional procedures,
such as advancement of the vastus medialis oblique or tibial
tubercle transfer, a slower and more cautious rehabilitation
may be required.11,40
Complications and Failure
PFA shares most of the complications with the TKA, such as
polyethylene wear, arthrofibrosis, and persistent pain. Early
complications, such as persistent anterior knee pain, patellar
catching or snapping, intraoperative fracture, and extensor
mechanism failure are more frequent in PFA than in TKA and
are mostly related to malpositioning.41,42 Conversely, loosen-
ing and infectionoccurat a lower rate comparedwithTKA.43,44
However, there are some specific early complications related
toPFAthat shouldbementioned.Onespecificcomplication is a
lateral swelling due to a hematomaafter bleeding in the lateral
compartment when a lateral release during PFA is performed.
Another common complication is patellar maltracking or
patellar instability due to failure of a medial ligament repair
or an inadequate tracking correction during surgery. Further-
more, peripatellar pain due to “overstuffing” of the patellar
component can occur. Another specific complication is lateral
catching due to wrong realignment of the extensor mechan-
ism, or more frequently, to poor trochlear component place-
ment, frequently related to a rotational malposition.45
Late complications requiring revision usually occur in the
setting of a well-functioning PFA. The most common cause of
latePFA failure isprogressionof tibiofemoralOA,accounting for
approximately 25% of the revision at 15 years of follow-up.46,47
Some authors reported that tibiofemoral OA progression is
more frequent in obese patients and when the indication is
primary PFOA compared with those affected by trochlear
dysplasia.10,46–50 Aseptic loosening is another possible cause
of revision and is more frequent in cementless PFA.10 Van der
List et al42 published a systematic review, including 39 studies
evaluating failures after PFA. The authors concluded that the
first cause of failure was tibiofemoral OA progression (38%),
pain (16%), aseptic loosening (14%), and patellar maltracking
(10%). Furthermore, pain was recognized as the first cause
(31%) of early failures (within 5 years), while OA progression
was more common in late failures (46%).
Results: Literature Review
The outcomes for PFAwere quite variable, mainly because of
the improvement in surgical technique, patient selection,
and implant design.51 A recent systematic review published
by van der List et al42 concluded that the survivorship of PFA
at 5-, 10-, 15-, and 20-year follow-upwas 91.7, 83.3, 74.9, and
66.6%, respectively. There were few studies comparing inlay
and onlay PFA. Van der List et al42 found that studies
published before 2010 reported a higher annual revision
rate when compared with more recently published studies
Fig. 1 Anteroposterior and lateral X-ray view after left PFA implants.
PFA, patellofemoral arthroplasty.
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(2.33 vs. 1.93). Furthermore, the authors reported good to
excellent results in 87.3% of the patients 5 years after surgery.
Similar to other studies, the authors concluded that better
long-term outcomes and survivorship could be expected
with second-generation implants.42,44
Dyet al44 performed ameta-analysis to compare complica-
tion, reoperation, and revision rate followingfirst- andsecond-
generation PFA and between PFA versus TKA for PFOA. The
authors concluded that there was a higher risk of reoperation
(OR: 4.33) and revision (OR: 4.93) infirst generation compared
with second-generation PFA.44
Inlay PFA
Tauro et al32 reviewed 66 inlay PFAs with 65% of survivorship
rateat8-year follow-upandonly45%ofgoodorexcellent results.
The most frequent cause of revision was patellar maltracking
and progression of tibiofemoral OA. Argenson et al10 reported
58% survival at 16-year follow-up, while Van Jonbergen et al27
reported 69% survivorship at 20-year follow-up. However, also
in these studies, themain reasons for revisionwere progression
of tibiofemoral OA and patellofemoral complications. Other
authors described an incidence of patellar maltracking after
inlay PFA ranged between 17 and 36%.17,32,35,52 The Australian
National Joint Replacement Registry reported that more than
20% of the implants needed a revision at 5-year follow-up.53 All
the studies are summarized in ►Table 2. In summary, results
with the first generation of PFA have been disappointing, with
high complication and failure rates.33
Onlay PFA
The second-generation PFA demonstrated significantly im-
proved short- and mid-term outcomes due to a careful patient
selection. The Australian National Joint Replacement Registry
reported less than10% revision rates foronlayPFAs.53Theonlay
design could reduce the incidence of patellarmaltracking to 1%
after PFA.49,54–56 Therefore, when patellar tracking was satis-
factory after PFA, revisions due to patellofemoral issues were
reduced, leaving progression of tibiofemoral OA as the first
cause of failure. Excellent results were reported by Ackroyd
et al54with a 5-year survivorship of 96%. Sisto et al,57 in a series
of custom-made implants, reported 100% survivorship at
6 years with good to excellent results in all the patients. Also,
Table 2 PFA inlay design results
Author N cases
(mean age)
Prosthesis design Follow-up
(y)
Revision
rate (%)
Good or excellent
results (%)
Blazina et al17 57 (39) Richards I & II 2 35 N/A
Arciero et al24 25 (62) Richards IICFS-Wright 5.3 28 85
Cartier et al72 72 (65) Richards I & II 4 7 85
Argenson et al10 66 (57) Autocentric 5.5 15 84
Krajca-Radcliffe and Coker46 16 (64) Richards I & II 5.8 6 88
Mertl et al73 51 (60) Spherocentric 3 6 82
Arnbjörnsson and Ryd74 113 (56) Multiple 7 22 75
De Cloedt et al75 45 (51) Autocentric 6 18 63
de Winter et al52 26 (59) Richards II 11 19 76
Tauro et al32 62 (66) Lubinus 7.5 28 45
Smith et al76 45 (72) Lubinus 4 19 64
Kooijman et al47 45 (50) Richards II 17 22 86
Board et al77 17 (66) Lubinus 1.5 35 53
Lonner35 30 (38) Lubinus 4 33 84
Merchant78 16 (47) LCS 4.5 0 94
Argenson et al79 66 (57) Autocentric 16.2 42 84
Cartier et al36 79 (60) Richards II & III 10 25 77
Sisto and Sarin57 25 (45) Kinematch 6 0 100
Jørgensen et al80 31(N/A) Richards II 7.7 3 65
Gadeyne et al81 43(67) Autocentric 6 24 72
van Wagenberg et al48 24 (64) Autocentric 4.8 29 30
van Jonbergen et al27 185 (52) Richards II 13.3 25 84
Charalambous et al82 51 (64) LCS 2 33 33
Hoogervorst et al83 33 (47) Richards II 9.7 21 90
Abbreviations: LCS, low contact stress; N, number; PFA, patellofemoral arthroplasty.
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Butler et al,58 in a smaller series of custom-made implants,
reported 91% survivorship at 5-year follow-up. Leadbetter
et al,49 in a series of 79 onlay PFAs, reported 94% survivorship
at a mean 3-year follow-upwith 84% good to excellent results.
Similar resultswere reportedbyother authors at 5-year follow-
up despite a 26% reoperation rate for lateral release, debride-
ment, tibial tubercle transfer, or arthroscopic assessment.59All
the studies are summarized in ►Table 3.
Patellofemoral Arthroplasty versus Total Knee
Arthroplasty
Several studies reported successful results after TKA for iso-
lated PFOAwith good mid-term results in approximately 90%
of patients. However, almost 19% of the patients still experi-
enced anterior knee pain after surgery.60–62 Dahm et al41
compared 33 patients who underwent PFA versus 22 patients
who underwent TKA for isolated PFOA with 2.5-year follow-
up. The group reported similar functional and pain scores but
higher activity scores in the PFA group. Furthermore, PFA
grouphad fewer complications, shorter postoperativehospital
stays, less blood loss, and a better postoperative flexion (127
vs. 118 degrees). Dy et al,44 in a meta-analysis, compared the
mid-term results and complications of PFA (inlay and onlay)
versus TKA. The authors concluded higher reoperation and
revision rates (odds ratio [OR] ¼ 8.06 and 8.11, respectively)
for PFA comparedwith TKA. However, when first- and second-
generation PFA were grouped separately, first-generation PFA
demonstrated a higher reoperation and revision rate (OR
¼ 4.33 and 4.39, respectively) comparedwith second-genera-
tion PFA, and there were no differences between second-
generation PFA and TKA regarding reoperation or revision
rate, pain, or mechanical complications.44 Lonner et al63 and
van Jonbergen et al64 compared the outcomes of TKA after
failed PFA to primary TKA. The studies reported similar out-
comes in both the groups, and no significant technical pro-
blems were described in TKA after PFA. These findings were
also confirmed by other studies. Several authors confirmed
that PFA could potentially delay TKA, by 10 to 15 years in up to
80% of the patients, and revision to TKA can be performed
without difficulty.15,41,50,54,63–65
Table 3 PFA onlay design results
Author N cases
(mean age)
Prosthesis design Follow-up
(y)
Revision
rate (%)
Good or excellent
results (%)
Lonner35 25 (44) Avon 0.5 0 96
Ackroyd and Chir18 306 (62) Avon 2 3.6 80
Cossey and Spriggins39 4 (52) Avon (Navigation) 1 0 100
Nicol et al50 103 (68) Avon 7.1 14 N/A
Ackroyd et al54 109 (68) Avon 5.2 15 80
Mohammed et al59 101 (57) Multiple 4 4 72
Butler and Shannon58 22 (49) Performa 5 14 N/A
Leadbetter et al49 79 (58) Avon 3 16 84
Starks et al55 37 (66) Avon 2 0 86
Odumenya et al37 50 (66) Avon 5.3 4 94
Gao et al84 11 (54) Avon 2 0 100
Sarda et al85 44 (62) Avon 4.5 5 85
Mont et al56 43 (49) Avon 7 12 N/A
Beitzel et al86 22 (46) Journey 2 0 N/A
Yadav et al87 51 (54) LCS 4.2 20 N/A
Davies et al88 52 (61) FPV 2 13 79
Hofmann et al89 40 (61) Natural Knee II 2.5 10 95
Morris et al90 31 (55) Multiple 2.5 3 N/A
Williams et al91 48 (63) FPV 2 15 N/A
Al-Hadity et al92 53 (62) FPV 3 3 97
Benazzo et al93 25 (67) Multiple 4.7 12 N/A
Dahm et al94 59 (56) Avon 4 3 N/A
Fink et al95 53 (61) Vanguard 3.7 6 N/A
Hernigou et al96 85 (71) Hermes 12 5 82
Akhbari et al97 61 (66) Avon 5 7 80
Liow et al98 51 (53) Sigma 4 8 76
Abbreviations: FPV, Femoro Patella Vialla; LCS, low contact stress; N, number; PFA, patellofemoral arthroplasty; N/A, not available.
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Patellofemoral Arthroplasty and Unicompartmental
Knee Arthroplasty
Currently, the association of PFA and UKA is one of the most
debated topics. Traditionally, PFA was contraindicated in
patients with evidence of tibiofemoral OA. Nowadays, with
recent implant design and improvement in surgical techni-
ques, combined PFA and medial or lateral tibiofemoral UKA
can be performed with good results.66,67 Furthermore, the
possibility to perform a UKA in cases of failure of PFA due to
medial or lateral tibiofemoral OA progression may avoid the
revision to TKA.33 Indeed, the association between PFA and
UKA allows for retaining of the medial pivot, with conse-
quent better knee kinematic.68 This procedure can be per-
formed in young patients or in elderly patients with severe
comorbidities because of the less invasiveness of the surgery
comparedwith TKA.23 Some authors have described promis-
ing results for PFA associated to UKA. Argenson et al67
reported optimal ROM and no postoperative pain in 17
patients treated with unlinked PFA and UKA. Heyse et al69
reported a 100% survivorship at 12-year follow-up in nine
patients treated with UKA and PFA. Kamath et al70 described
an improvement in all 21 patients treated with PFA and UKA
at 2-year follow-up and reported only one significant com-
plication (knee instability). Parratte et al71 reported a 54%
survivorship at 17-year follow-up in 77 knees with a good
satisfaction rate. Also, Sabatini et al23 reported an improve-
ment in functional and clinical scores at 18-month follow-up
in a case series of six knees treatedwith isolated PFA and nine
knees treated with combined PFA and UKA. However, few
studies are available that have evaluated the association of
PFA and UKA, with small numbers and short follow-ups.
Conclusion
PFAhasshowntobeaviableoptionfor the treatmentof isolated
PFOA. The ideal candidate for a PFA is a middle-aged female
with PFOA not responsive to the conservative treatment and
without significant malalignment or tibiofemoral OA. Modern
PFA design onlay style, strict patient selection, and improve-
ment in surgical techniques have produced satisfactory results
in the past decades in short- to mid-term follow-up, with 10-
years of survivorship of almost 90%. The main cause of failure
of second-generation PFA is progression of tibiofemoral OA.
However, the introduction of the association of PFA and UKA
may reduce the need for revision toTKAdue to tibiofemoral OA
progression. Despite the good mid-term outcomes after PFA,
futureresearch iswarrantedtoevaluate thelong-termresultsof
the second-generation PFA, and eventually, the efficacy of
combination of PFA and UKA in comparison with TKA.
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